If Senate Does Not Pass OTC Monograph Reform, Bill Could Stall In 2019

Health care watchers predict that if OTC monograph reform legislation does not make it to the president before the end of the year, renewed debates around the legislation’s industry incentives could stall the bill in 2019, especially if New Jersey Democrat Frank Pallone, who was critical of the incentives included in the House-passed bill, becomes the new Energy & Commerce chair. Even with those concerns, the over-the-counter drug industry remains hopeful that the bill will pass the Senate in the...